Curcumin compound reactivates Epstein–Barr virus, offering safer cancer therapy

A novel curcumin derivative, C210, activates the Epstein–Barr virus (EBV) lytic cycle without producing infectious virions by disrupting HSP90. This discovery opens avenues for safer EBV-positive cancer therapies.

Latest GTBIF Stock analysis and (How to make money trading GTBIF Stock)

July 13, 2023

FDA approves GSK’s Jemperli for frontline use in certain advanced endometrial cancers

GSK’s new cancer drug Jemperli (dostarlimab) won an FDA approval on Monday, almost two months ahead of its PDUFA date, for use in certain frontline

August 1, 2023

How health care systems can protect patients from sexual assault by providers

Health care providers have a sacrosanct relationship with patients. That unique position of trust also puts them in a position of power over their patients.

September 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.